CC
Commodore Capital Portfolio holdings
AUM
$1.42B
This Quarter Return
+36.05%
1 Year Return
+73.3%
3 Year Return
+1,330.82%
5 Year Return
–
10 Year Return
–
AUM
$622M
AUM Growth
+$622M
(+31%)
Cap. Flow
+$76.5M
Cap. Flow
% of AUM
12.3%
Top 10 Holdings %
Top 10 Hldgs %
69.69%
Holding
34
New
10
Increased
3
Reduced
3
Closed
4
Top Buys
| 1 |
Akero Therapeutics
AKRO
|
$25.3M |
| 2 |
Viridian Therapeutics
VRDN
|
$21.7M |
| 3 |
THRD
Third Harmonic Bio
THRD
|
$19.3M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
$17.7M |
| 5 |
Acumen Pharmaceuticals
ABOS
|
$11M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$23.2M |
| 2 |
Kura Oncology
KURA
|
$12.7M |
| 3 |
VistaGen Therapeutics
VTGN
|
$11.5M |
| 4 |
Cogent Biosciences
COGT
|
$9.32M |
| 5 |
Tenaya Therapeutics
TNYA
|
$2.01M |
Sector Composition
| 1 | Healthcare | 99.6% |
| 2 | Financials | 0.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Esperion Therapeutics
ESPR
$474M
| $3.13M | 0.5% |
+467,468
| New | +$3.13M |
|
27
Immunic
IMUX
$76.8M
| $2.82M | 0.45% |
893,013
| – | – |
|
|
BLSA
28
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $2.51M | 0.4% |
250,000
| – | – |
|
29
Larimar Therapeutics
LRMR
$326M
| $2.4M | 0.39% |
+750,000
| New | +$2.4M |
|
30
Terns Pharmaceuticals
TERN
$638M
| $1.21M | 0.2% |
+205,870
| New | +$1.21M |
|
|
IVA
31
Inventiva
IVA
$780M
| – | – |
-175,500
| Closed | -$995K |
|
|
32
Tenaya Therapeutics
TNYA
$189M
| – | – |
-357,699
| Closed | -$2.01M |
|
|
33
VistaGen Therapeutics
VTGN
$109M
| – | – |
-13,049,079
| Closed | -$11.5M |
|
|
ISEE
34
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-2,409,961
| Closed | -$23.2M |
|